Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gianni Ghetti
Observed name:
G Ghetti
ORCID:
0000-0001-6809-5251
Observed ORCID:
0000-0001-6809-5251
OpenAlex ID:
A5031162466
Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis
2018
·
Stefan Schraag
, Lorenzo Pradelli
, et al.
·
BMC Anesthesiology
·
231
PDF
State-of-the-art review on AL amyloidosis in Western Countries: Epidemiology, health economics, risk assessment and therapeutic management of a rare disease
2023
·
Alice Sabinot
, Gianni Ghetti
, et al.
·
Blood Reviews
·
33
A computational framework for modeling and studying pertussis epidemiology and vaccination
2020
·
Paolo Castagno
, Simone Pernice
, et al.
·
BMC Bioinformatics
·
22
PDF
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
2024
·
Gianni Ghetti
, Francesco Saverio Mennini
, et al.
·
Clinical Drug Investigation
·
17
PDF
A general model for the estimation of societal costs of lost production and informal care in Italy
2017
·
Lorenzo Pradelli
, Gianni Ghetti
·
Farmeconomia Health economics and therapeutic pathways
·
15
PDF
Multiple Myeloma in Italy: An Epidemiological Model by Treatment Line and Refractoriness Status
2024
·
Roberto Mina
, Silvia Mangiacavalli
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
7
Quality-Adjusted Life Expectancy Norms for Italy
2023
·
Gianni Ghetti
, Massimiliano Povero
·
Value in Health
·
6
Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy
2021
·
Gianni Ghetti
, Maria Claudia D'Avella
, et al.
·
ClinicoEconomics and Outcomes Research
·
6
PDF
A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In Italy
2016
·
L Pradelli
, G Ghetti
·
Value in Health
·
4
Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations
2019
·
Orietta Zaniolo
, Gianni Ghetti
, et al.
·
Farmeconomia Health economics and therapeutic pathways
·
3
PDF
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy
2025
·
Ilaria Valentini
, Gianni Ghetti
, et al.
·
The European Journal of Health Economics
·
2
PDF
CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece
2023
·
Gianni Ghetti
, Lorenzo Pradelli
, et al.
·
ClinicoEconomics and Outcomes Research
·
2
PDF
Cost Evaluation and Economic Sustainability of Enzyme Replacement Therapies for Fabry Disease in Italy from the Hospital Perspective
2025
·
Gianni Ghetti
, Eleonora Spiombi
, et al.
·
Farmeconomia Health economics and therapeutic pathways
·
1
Retifanlimab Vs Avelumab in Patients with Metastatic Merkel Cell Carcinoma: A Cost Utility Analysis in Italy
2025
·
Gianni Ghetti
, Camilla Porta
, et al.
·
Farmeconomia Health economics and therapeutic pathways
·
1
Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy
2022
·
Edoardo Mannucci
, Gianni Ghetti
·
Farmeconomia Health economics and therapeutic pathways
·
1
PDF
Retifanlimab Versus Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma: A Matching-Adjusted Indirect Comparison Analysis
2026
·
Camilla Porta
, Gianni Ghetti
, et al.
·
Advances in Therapy
PDF
Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy
2026
·
Gianni Ghetti
, Luca Castello
, et al.
·
ClinicoEconomics and Outcomes Research
EE635 Real-World Cost-Utility of Faricimab vs. Current and Future Anti-VEGF Therapies in Patients With Neovascular Age-Related Macular Degeneration in Italy
2025
·
Camilla Porta
, Gianni Ghetti
, et al.
·
Value in Health
EE461 Faricimab vs. Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration: A Cost-Utility Analysis in Italy
2025
·
Camilla Porta
, Gianni Ghetti
, et al.
·
Value in Health
Show more works
View as search
Works count:
19
Citation count:
351
H-index:
6
I10-index:
5
Year
Topic
Type